
CR2O - We are your clinical development partner
CR2O is a full-service clinical CRO founded in 2012, with its headquarters near Utrecht, The Netherlands. We offer agile teams that effectively navigate clinical development activities …
We care, we own, we deliver, and we engage - CR2O
We are committed with enthusiasm to the responsibilities that we assume towards customers and partners. We are constantly developing and stimulating ourselves to be able to take on the …
Our latest news and updates - CR2O
2024年2月15日 · CR2O is a leading European clinical CRO, specialised in managing and operating early-stage infectious disease clinical trials. Artemis Bioservices is a specialty lab, …
We offer the full range of clinical trial services - CR2O
At CR2O, we have a highly motivated and experienced cross-functional team that helps you to effectively bring your project to the clinic. Our integrated project teams enable seamless …
Meet our team of Life Sciences professionals - CR2O
At CR2O, we employ highly qualified and experienced Life Sciences professionals. Supported by a rigorous quality management system and continuous training programs, our people are …
We offer the full range of clinical trial services - CR2O
At CR2O, we have a highly motivated and experienced cross-functional team that helps you to effectively bring your project to the clinic. Our integrated project teams enable seamless …
Biointelect and CR2O forge new strategic partnership to provide ...
Based in the Netherlands, CR2O is expanding Biointelect’s existing capability to include clinical trial capabilities across the European Union and Australia. The partnership will give CR2O …
Category: Company Updates - CR2O
2023年5月21日 · CR2O is a leading European clinical CRO, specialised in managing and operating early-stage infectious disease clinical trials. Artemis Bioservices is a specialty lab, …
Initiation of the First-in-Human trial with Dyadic’s SARS ... - cr2o.nl
Dyadic has entered into a master services agreement with CR2O, as full-service global contract research organization specializing in vaccinology, to manage preclinical and clinical …
LARISSA consortium reaches milestone: Novel Rift Valley fever
Following a single dose administration, the candidate vaccine is expected to generate a long-lasting immune response against Rift Valley fever, a severe and deadly disease predominantly …